These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 33092251)

  • 1. Recycling the Purpose of Old Drugs to Treat Ovarian Cancer.
    Nunes M; Henriques Abreu M; Bartosch C; Ricardo S
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current state and outlook for drug repositioning anticipated in the field of ovarian cancer.
    Kobayashi Y; Banno K; Kunitomi H; Tominaga E; Aoki D
    J Gynecol Oncol; 2019 Jan; 30(1):e10. PubMed ID: 30479094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of "Repurposed" Drugs in the Treatment of Epithelial Ovarian Cancer: A Systematic Review.
    Goenka L; Dubashi B; Selvarajan S; Ganesan P
    Am J Clin Oncol; 2022 Apr; 45(4):168-174. PubMed ID: 35320817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential to treat lung cancer via inhalation of repurposed drugs.
    Lee WH; Loo CY; Ghadiri M; Leong CR; Young PM; Traini D
    Adv Drug Deliv Rev; 2018 Aug; 133():107-130. PubMed ID: 30189271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Old wine in new bottles: Drug repurposing in oncology.
    Antoszczak M; Markowska A; Markowska J; Huczyński A
    Eur J Pharmacol; 2020 Jan; 866():172784. PubMed ID: 31730760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug Repositioning for Ovarian Cancer Treatment: An Update.
    Cavalluzzi MM; Viale M; Rotondo NP; Ferraro V; Lentini G
    Anticancer Agents Med Chem; 2024; 24(8):637-647. PubMed ID: 38367265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing Immunotherapy in Ovarian Cancer: The Emerging Role of Metformin and Statins.
    Almeida-Nunes DL; Silvestre R; Dinis-Oliveira RJ; Ricardo S
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins as Potential Chemoprevention or Therapeutic Agents in Cancer: a Model for Evaluating Repurposed Drugs.
    Joharatnam-Hogan N; Alexandre L; Yarmolinsky J; Lake B; Capps N; Martin RM; Ring A; Cafferty F; Langley RE
    Curr Oncol Rep; 2021 Feb; 23(3):29. PubMed ID: 33582975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins as adjuvants in the treatment of ovarian cancer: Controversy and misunderstanding.
    Manzano-León N; Garcia-Lopez P
    Eur J Pharmacol; 2021 Apr; 896():173915. PubMed ID: 33513335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Common Pharmaceutical Agents on the Prevention and Treatment of Pancreatic Cancer.
    Amin S; Boffetta P; Lucas AL
    Gut Liver; 2016 Sep; 10(5):665-71. PubMed ID: 27563018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common medications and survival in women with ovarian cancer: A systematic review and meta-analysis.
    Majidi A; Na R; Dixon-Suen S; Jordan SJ; Webb PM
    Gynecol Oncol; 2020 Jun; 157(3):678-685. PubMed ID: 32317171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoresistance in ovarian cancer: exploiting cancer stem cell metabolism.
    Li SS; Ma J; Wong AST
    J Gynecol Oncol; 2018 Mar; 29(2):e32. PubMed ID: 29468856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Insight into Drug Repositioning for the Development of Novel Anti-Cancer Drugs.
    Bhattarai D; Singh S; Jang Y; Hyeon Han S; Lee K; Choi Y
    Curr Top Med Chem; 2016; 16(19):2156-68. PubMed ID: 26881715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond aspirin-cancer prevention with statins, metformin and bisphosphonates.
    Gronich N; Rennert G
    Nat Rev Clin Oncol; 2013 Nov; 10(11):625-42. PubMed ID: 24080598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repurposing of drugs approved for cardiovascular diseases: Opportunity or mirage?
    Gelosa P; Castiglioni L; Camera M; Sironi L
    Biochem Pharmacol; 2020 Jul; 177():113895. PubMed ID: 32145263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposed Drugs Trials for Ovarian Cancer.
    DiFeo A
    Cancer J; 2019; 25(2):149-152. PubMed ID: 30896539
    [No Abstract]   [Full Text] [Related]  

  • 17. Screening a library of approved drugs reveals that prednisolone synergizes with pitavastatin to induce ovarian cancer cell death.
    Abdullah MI; Abed MN; Khanim F; Richardson A
    Sci Rep; 2019 Jul; 9(1):9632. PubMed ID: 31270377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic options following second-line platinum-based chemotherapy in patients with recurrent ovarian cancer: Comparison of active surveillance and maintenance treatment.
    Ray-Coquard I; Mirza MR; Pignata S; Walther A; Romero I; du Bois A
    Cancer Treat Rev; 2020 Nov; 90():102107. PubMed ID: 33099187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using a novel computational drug-repositioning approach (DrugPredict) to rapidly identify potent drug candidates for cancer treatment.
    Nagaraj AB; Wang QQ; Joseph P; Zheng C; Chen Y; Kovalenko O; Singh S; Armstrong A; Resnick K; Zanotti K; Waggoner S; Xu R; DiFeo A
    Oncogene; 2018 Jan; 37(3):403-414. PubMed ID: 28967908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is antidyslipidemic statin use for cancer prevention a promising drug repositioning approach?
    Kobayashi Y; Banno K; Kunitomi H; Nagai S; Takahashi T; Anko M; Iijima M; Takeda T; Matoba Y; Nakamura K; Tsuji K; Tominaga E; Aoki D
    Eur J Cancer Prev; 2019 Nov; 28(6):562-567. PubMed ID: 30418231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.